About us


The fruit of a collaboration between industry and research

The development of Neolys Diagnostics tests is the result of a meeting between industry and radiobiology researchers from Lyon (INSERM unit).

Reliable technology

First of all, our team has developed a reliable technology, based on the implementation of predictive tests, allowing the personalization of radiotherapy treatments.

We are responding to a need: to predict the radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.


We promote fundamental values, characteristic of our commitment and our work: the respect of biomedical ethics, a will to improve patients’ care and quality of life. For us, the patient is our priority. These values are reflected in our actions:

Our team

Our team is mainly composed of professional biology researchers, specialized in radiobiology.

Sandrine Pereira

R&D Director

PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.

Elise Berthel

R&D Manager - Project Manager

PhD in radiobiology, Elise supervises the company’s research and development unit.

Patrick Barhoum

Business Developer

Phd in science specialising in chemistry and biology and a master’s degree in innovation management. Patrick is in charge of business development.

Mirlande Duclos

Laboratory technician

Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.

Our partners